285
Views
56
CrossRef citations to date
0
Altmetric
Drug Evaluation

A review of acitretin, a systemic retinoid for the treatment of psoriasis

&
Pages 1725-1734 | Published online: 08 Aug 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

İpek Erol, Neslihan Üstündağ Okur, Duygu Orak, Hande Sipahi, Ahmet Aydın & Özgen Özer. (2020) Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect. Pharmaceutical Development and Technology 25:8, pages 909-918.
Read now
Roxanne Pinson, Bahman Sotoodian & Loretta Fiorillo. (2016) Psoriasis in children. Psoriasis: Targets and Therapy 6, pages 121-129.
Read now
Markus Wuenschel & Per Trobisch. (2010) Achilles tendon ossification after treatment with acitretin. Journal of Dermatological Treatment 21:2, pages 111-113.
Read now
Ramon Alvin Chua, Jack L. Arbiser, Ramon Alvin Chua & Jack L. Arbiser. (2009) The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity 42:7, pages 574-579.
Read now
Malleswara Rao Peram, Chandrakant Dhananjay, Nagesh Chandrasekhar, Vijay M Kumbar, Vidyadhara Suryadevara, Sachin R Patil & Sally A El-Zahaby. Acitretin-loaded nanoethosomal gel for the treatment of psoriasis: Formulation, optimization, in vitro, and in vivo assessment. Journal of Dispersion Science and Technology 0:0, pages 1-18.
Read now

Articles from other publishers (51)

Haihan Zhang, Matthew T Patrick, Trilokraj Tejasvi, Mrinal K Sarkar, Rachael Wasikowski, Philip E Stuart, Qinmengge Li, Xianying Xing, John J Voorhees, Nicole L Ward, Kevin He, Xiang Zhou, Johann E Gudjonsson, Rajan P Nair, James T Elder & Lam C Tsoi. (2023) Retrospective pharmacogenetic study of psoriasis highlights the role of KLK7 in tumour necrosis factor signalling . British Journal of Dermatology.
Crossref
Emad M. Elzayat, Sherif A. Shahien, Ahmed A. El-Sherif & Mohamed Hosney. (2023) miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease. Journal of Alzheimer's Disease 94:s1, pages S203-S225.
Crossref
Hassan Raza, Shefaat Ullah Shah, Zakir Ali, Atif Ullah Khan, Irfa Basharat Rajput, Arshad Farid, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Maitham A. Al Hawaj, Saima Mahmood, Abid Hussain & Kifayat Ullah Shah. (2022) In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis. Gels 8:11, pages 746.
Crossref
Jong Heon Jeong, Gyu Hwan Hyun, Yu Jeong Park, Sung Won Kwon & Ai-Young Lee. (2022) Clinical Factors Affecting the Serum Retention of a Teratogenic Etretinate after the Acitretin Administration. Biomolecules & Therapeutics 30:6, pages 562-569.
Crossref
Klasiena Bouwman, Pim Aarts, Koen Dudink, Jiasi Hao, Behrooz Z. Alizadeh, Lisette M. Prens, Allard R. J. V. Vossen, Kelsey R. van Straalen, Hessel H. van der Zee & Barbara Horváth. (2022) Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study. American Journal of Clinical Dermatology 23:6, pages 905-914.
Crossref
Jiajia Lan, Yuce Li, Jingjing Wen, Yu Chen, Jing Yang, Liang Zhao, Yuting Xia, Hongyao Du, Juan Tao, Yan Li & Jintao Zhu. (2022) Acitretin-Conjugated Dextran Nanoparticles Ameliorate Psoriasis-like Skin Disease at Low Dosages. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Arya K. Ramanunny, Sheetu Wadhwa, Divya Thakur, Sachin K. Singh & Rajesh Kumar. (2021) Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:3, pages 418-433.
Crossref
Nikolay N. Murashkin, Eduard T. Ambarchian, Roman V. Epishev, Alexander I. Materikin, Leonid A. Opryatin, Roman A. Ivanov, Daria S. Kukoleva, Marina Y. Pomazanova, Daria G. Kuptsova, Yana V. Kozyr & Andrey L. Bakulev. (2020) Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study. Current Pediatrics 19:6, pages 531-537.
Crossref
Navjot Kaur, Manjot Kaur, Manishi Mahajan & Subheet Kumar Jain. (2020) Development, characterization and evaluation of nanocarrier based formulations of antipsoriatic drug “acitretin” for skin targeting. Journal of Drug Delivery Science and Technology 60, pages 102010.
Crossref
Deepak M. W. Balak, Sascha Gerdes, Aurora Parodi & Laura Salgado-Boquete. (2020) Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature. Dermatology and Therapy 10:4, pages 589-613.
Crossref
Mohamed Haider, Shifaa M. Abdin, Leena Kamal & Gorka Orive. (2020) Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics 12:3, pages 288.
Crossref
Arya Kadukkattil Ramanunny, Sheetu Wadhwa, Sachin Kumar Singh, Deep Shikha Sharma, Rubiya Khursheed & Ankit Awasthi. (2020) Treatment Strategies Against Psoriasis: Principle, Perspectives and Practices. Current Drug Delivery 17:1, pages 52-73.
Crossref
Chovatiya & Silverberg. (2019) Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children. Children 6:10, pages 108.
Crossref
Muzamil Amin Chisti, Yousef Binamer, Abdullah Alfadley & Abdulmonem Almutawa. (2019) D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin. Annals of Saudi Medicine 39:1, pages 56-60.
Crossref
Shivani B. Kaushik & Mark G. Lebwohl. (2019) Psoriasis: Which therapy for which patient. Journal of the American Academy of Dermatology 80:1, pages 43-53.
Crossref
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti & Giovanni Damiani. (2018) Liver Illness and Psoriatic Patients. BioMed Research International 2018, pages 1-12.
Crossref
Tripti Shukla, Neeraj Upmanyu, Sharad Prakash Pandey & Dipanjana Gosh. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting 1 47 .
Maria Relvas & Tiago Torres. (2017) Pediatric Psoriasis. American Journal of Clinical Dermatology 18:6, pages 797-811.
Crossref
Sebastian Wetzel, Lisa Seipold & Paul Saftig. (2017) The metalloproteinase ADAM10: A useful therapeutic target?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:11, pages 2071-2081.
Crossref
L. S. Namazova-Baranova, N. N. Murashkin, EH. T. Ambarchyan & A. I. Materikin. (2017) SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I). Vestnik dermatologii i venerologii 93:4, pages 74-81.
Crossref
Daniel J. No, Mina Amin & Jashin J. Wu. 2017. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis 7 12 .
Collin M. Blattner, Soham P. Chaudhari, John YoungIIIIII & Jenny E. Murase. (2016) A dermatologist guide to immunogenicity. International Journal of Women's Dermatology 2:3, pages 77-84.
Crossref
Maddalena Napolitano, Matteo Megna, Anna Balato, Fabio Ayala, Serena Lembo, Alessia Villani & Nicola Balato. (2016) Systemic Treatment of Pediatric Psoriasis: A Review. Dermatology and Therapy 6:2, pages 125-142.
Crossref
I. E. Deckers & E. P. Prens. (2015) An Update on Medical Treatment Options for Hidradenitis Suppurativa. Drugs 76:2, pages 215-229.
Crossref
Elaine J. Lin, Vidhi V. Shah, Shivani P. Reddy & Jashin J. Wu. 2016. Therapy for Severe Psoriasis. Therapy for Severe Psoriasis 49 62 .
Cenk Akçali, Ebru Homurlu Guven, Necmettin Kirtak, H Serhat Inaloz, Orhan Ozgoztasi & Ulas Guvenc. (2014) Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis. Journal of International Medical Research 42:5, pages 1118-1122.
Crossref
Sebastian Bernardo & Mark Lebwohl. 2014. Acneiform Eruptions in Dermatology. Acneiform Eruptions in Dermatology 295 307 .
G. Carretero, M. Ribera, I. Belinchón, J.M. Carrascosa, Ll. Puig, C. Ferrandiz, L. Dehesa, D. Vidal, F. Peral, E. Jorquera, A. Gonzalez-Quesada, C. Muñoz, J. Notario, F. Vanaclocha & J.C. Moreno. (2013) Guidelines for the Use of Acitretin in Psoriasis. Actas Dermo-Sifiliográficas (English Edition) 104:7, pages 598-616.
Crossref
G. Carretero, M. Ribera, I. Belinchón, J.M. Carrascosa, Ll. Puig, C. Ferrandiz, L. Dehesa, D. Vidal, F. Peral, E. Jorquera, A. Gonzalez-Quesada, C. Muñoz, J. Notario, F. Vanaclocha & J.C. Moreno. (2013) Acitretina: guía de uso en psoriasis. Actas Dermo-Sifiliográficas 104:7, pages 598-616.
Crossref
Ann L. Marqueling & Kelly M. Cordoro. (2013) Systemic Treatments for Severe Pediatric Psoriasis. Dermatologic Clinics 31:2, pages 267-288.
Crossref
Xinwu NIU, Wei CAO, Huiqun MA, Jie FENG, Ximei LI & Xinhua ZHANG. (2012) Acitretin exerted a greater influence on T ‐helper ( T h)1 and T h17 than on T h2 cells in treatment of psoriasis vulgaris . The Journal of Dermatology 39:11, pages 916-921.
Crossref
Kristina Endres & Falk Fahrenholz. (2011) Regulation of alpha-secretase ADAM10 expression and activity. Experimental Brain Research 217:3-4, pages 343-352.
Crossref
Yoshinori Umezawa, Tomotaka Mabuch & Akira Ozawa. (2012) Generalized Pustular Psoriasis in a Child: Observation of Long‐Term Combination Therapy with Etretinate and Calcipotriol for 16 Years. Pediatric Dermatology 29:2, pages 206-208.
Crossref
José Carlos Ruiz Carrascosa. 2012. Manual de comorbilidad cardiovascular y síndrome metabólico en la psoriasis. Manual de comorbilidad cardiovascular y síndrome metabólico en la psoriasis 63 91 .
Rodrigo da Mota & Bernhard Homey. 2012. Kanerva's Occupational Dermatology. Kanerva's Occupational Dermatology 1045 1051 .
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines 205 317 .
Laura Roosevelt & Jason Emer. (2018) Pustular Psoriasis: A Practical Review of the Literature. Psoriasis Forum 17a:1, pages 33-41.
Crossref
Yogeeta Agrawal, Kailash C. Petkar & Krutika K. Sawant. (2010) Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International Journal of Pharmaceutics 401:1-2, pages 93-102.
Crossref
Kirsten D. Mertz, Madeleine Pfaltz, Tobias Junt, Mirka Schmid, Maria Teresa Fernandez Figueras, Katrin Pfaltz, André Barghorn & Werner Kempf. (2010) Merkel cell polyomavirus is present in common warts and carcinoma in situ of the skin. Human Pathology 41:10, pages 1369-1379.
Crossref
S. M. Breathnach, C. H. Smith, R. J. G. Chalmers & R. J. Hay. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 53 .
A A KUBANOVA, A A KUBANOV, J F NIKOLAS, L PUIG, J PRINCE, O R KATUNINA & L F ZNAMENSKAYA. (2010) Immune mechanisms of psoriasis. New strategies of biotherapy. Vestnik dermatologii i venerologii 86:1, pages 35-47.
Crossref
Frank Tippmann, Jana Hundt, Anja Schneider, Kristina Endres & Falk Fahrenholz. (2009) Up‐regulation of the α‐secretase ADAM10 by retinoic acid receptors and acitretin. The FASEB Journal 23:6, pages 1643-1654.
Crossref
Kelly M. Cordoro. (2008) Management of Childhood Psoriasis. Advances in Dermatology 24, pages 125-169.
Crossref
Vincent C. O. Njar. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets 389 407 .
Edward Hsia, Michael J. Johnston, Robert J. Houlden, Wendy H. Chern & Hans E.J. Hofland. (2008) Effects of Topically Applied Acitretin in Reconstructed Human Epidermis and the Rhino Mouse. Journal of Investigative Dermatology 128:1, pages 125-130.
Crossref
Aram Boada Garcia & Miquel Ribera Pibernat. (2007) Actualización en el uso del acitretino en la psoriasis. Piel 22:9, pages 459-464.
Crossref
M. Antonia Lafarga Giribets, Antoni García Bernaus & Joan Pere Fabregat Sanjuán. (2007) Psoriasis cutánea: evolución sin tratamiento. FMC - Formación Médica Continuada en Atención Primaria 14:7, pages 421-422.
Crossref
Ramon Ruiz-Maldonado, Carola Durán-Mckinster & Carola Durán-Mckinster. 2007. Retinoids and Carotenoids in Dermatology. Retinoids and Carotenoids in Dermatology 171 182 .
Peter C. M. Van de Kerkhof & Christel J. Verfaille. 2007. Retinoids and Carotenoids in Dermatology. Retinoids and Carotenoids in Dermatology 125 152 .
Alpesh Desai, Francisca Kartono & James Q. Del Rosso. (2007) Systemic Retinoid Therapy: A Status Report on Optimal Use and Safety of Long-Term Therapy. Dermatologic Clinics 25:2, pages 185-193.
Crossref
Peter C. M. van de Kerkhof. (2006) Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatologic Therapy 19:5, pages 252-263.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.